Evidence map›Paper›PMID 35494042›Full record

ArticleFrontiers in oncology2022

Imaging Biomarkers in Prostate Stereotactic Body Radiotherapy: A Review and Clinical Trial Protocol.

Wei Liu, Andrew Loblaw, David Laidley, Hatim Fakir, Lucas Mendez, Melanie Davidson, Zahra Kassam, Ting-Yim Lee, Aaron Ward, Jonathan Thiessen and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

Wei LiuDepartment of Oncology, Division of Radiation Oncology, London Health Sciences Centre and Western University, London, ON, Canada.
Andrew LoblawDepartment of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre and Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
David LaidleyDivision of Nuclear Medicine, St. Joseph's Health Centre and Western University, London, ON, Canada.
Hatim FakirDepartment of Oncology and Department of Medical Biophysics, London Health Sciences Centre and Western University, London, ON, Canada.
Lucas MendezDepartment of Oncology, Division of Radiation Oncology, London Health Sciences Centre and Western University, London, ON, Canada.
Melanie DavidsonDepartment of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre and Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
Zahra KassamDepartment of Medical Imaging, St. Joseph's Health Care and Western University, London, ON, Canada.
Ting-Yim LeeDepartment of Medical Biophysics, Western University and Lawson Health Research Institute, London, ON, Canada.
Aaron WardDepartment of Medical Biophysics, Western University and Lawson Health Research Institute, London, ON, Canada.
Jonathan ThiessenDepartment of Medical Biophysics, Western University and Lawson Health Research Institute, London, ON, Canada.
Jane BayaniOntario Institute for Cancer Research and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
John ConynghamPatient Partner, London, ON, Canada.
Laura BaileyClinical Research Unit, London Regional Cancer Program, London, ON, Canada.
Joseph D AndrewsClinical Research Unit, London Regional Cancer Program, London, ON, Canada.
Glenn BaumanDepartment of Oncology, Division of Radiation Oncology, London Health Sciences Centre and Western University, London, ON, Canada.
Western University · CALondon Health Sciences Centre · CACancer Care Ontario · CASunnybrook Health Science Centre · CASt Joseph's Health Care · CASt Joseph's Health Centre · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in imaging have changed prostate radiotherapy through improved biochemical control from focal boost and improved detection of recurrence. These advances are reviewed in the context of prostate stereotactic body radiation therapy (SBRT) and the ARGOS/CLIMBER trial protocol. ARGOS/CLIMBER will evaluate 1) the safety and feasibility of SBRT with focal boost guided by multiparametric MRI (mpMRI) and

Indexed as

MRIprostate cancerPSMA PETSBRTstereotacticultrahypofractionated

Identifiers

PMID35494042
PMCPMC9043802
OpenAlexW4224087801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.